Company Profile

Nininger Medical Inc
Profile last edited on: 12/14/21      CAGE:       UEI: FYZCAFF5H1D6

Business Identifier: Transcatheter heart valve therapies
Year Founded
2019
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

815 Lime Street
Brea, CA 92821
   (909) 213-5840
   inquiries@niningermed.com
   www.niningermed.com
Location: Single
Congr. District: 39
County: Orange

Public Profile

Nininger Medical is structured around advancing transcatheter heart valve therapies by tackling development of new devices for the treatment of unmet needs in structural heart disease. Principals of the firm arecurrently addressing development of a life-saving technology for Transcatheter Tricuspid Valve Replacement. Using a novel material that is 10 times thinner than those used for most heart valve replacements, the focus is on enabling the use of a device that can be delivered through a smaller catheter.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NSF $256,000
Project Title: Transcatheter Tricuspid Valve Replacement using Physical Vapor Deposition Thin-Films

Key People / Management

  Daniel Anderson -- Co-Founder

  Lowie Van Assche -- Co-Founder and Chief Medical Officer

Company News

There are no news available.